“PAK4抑制通过抑制Wnt/β-catenin， p-ERK/MAPK和p-AKT/PI3K通路显著增强吉西他滨在PDAC细胞中的活性”[生物化学和生物物理报告，（35），2023,1-8 / 101544]。

IF 2.2 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY

Biochemistry and Biophysics Reports Pub Date : 2025-08-09 eCollection Date: 2025-09-01 DOI:10.1016/j.bbrep.2025.102201

Charudatt Samant, Ramesh Kale, Anand Bokare, Mahip Verma, K Sreedhara Ranganath Pai, Mandar Bhonde

引用次数: 0

摘要

[这更正了文章DOI: 10.1016/j.bbrep.2023.101544.]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Corrigendum to "PAK4 inhibition significantly potentiates gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathways" [Biochemistry and Biophysics Reports, (35), September 2023, 1-8 / 101544].

[This corrects the article DOI: 10.1016/j.bbrep.2023.101544.].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Biochemistry and Biophysics Reports Biochemistry, Genetics and Molecular Biology-Biophysics

CiteScore

4.60

自引率

0.00%

发文量

191

审稿时长

59 days

期刊介绍： Open access, online only, peer-reviewed international journal in the Life Sciences, established in 2014 Biochemistry and Biophysics Reports (BB Reports) publishes original research in all aspects of Biochemistry, Biophysics and related areas like Molecular and Cell Biology. BB Reports welcomes solid though more preliminary, descriptive and small scale results if they have the potential to stimulate and/or contribute to future research, leading to new insights or hypothesis. Primary criteria for acceptance is that the work is original, scientifically and technically sound and provides valuable knowledge to life sciences research. We strongly believe all results deserve to be published and documented for the advancement of science. BB Reports specifically appreciates receiving reports on: Negative results, Replication studies, Reanalysis of previous datasets.